BRAF and neoplasm: As previously mentioned, since the current management of advanced-stage melanomas is greatly determined by the presence or absence of BRAF mutations, identifying specific dermoscopic features associated with BRAF mutational status before tumor excision could be of great importance in making further diagnostic and therapeutic decisions.